The expression of PLK1 and PLK3 was elevated in a fraction of cystadenomas and was even higher in the group of primary ovarian carcinomas, whereas borderline tumours tended to express lower levels of PLK1 and PLK3 compared to other epithelial tumour entities of the ovary. This evidence concerns the gene PLK3 and cystadenoma.